Publication: 2657

Axillary Management of Stage II/III Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-positive) and CALGB 40603 (Triple-negative)
      QxMD      Google Scholar   
Citation:
J Am Coll Surg vol 224 (4) 688-94
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
2442  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, U10 CA180838  
Corr. Author:
 
Authors:
                 
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40601, CALGB-40603
Phases:
2, 3
Keywords:
Article